Applying a model of policy design to analyze Norwegian and Swiss policy documents on global health
Two policy documents were used as data: the Norwegian White Paper on Global Health and Development and the Swiss Health Foreign Policy. They were formally adopted in their respective countries in 2012.
Both documents were coded manually using the six categories of Schneider and Ingram’s core components of policy design. In subsequent rounds of coding, expert consultation and analysis, the components and sub-categories were adapted.
The results highlight notable differences in both countries’ techniques for acting on global health and in their justifications for taking such action. However, both policies do not target individuals or populations for interventions, but rather the systems of global health actors. They aim to effect change in diverse policy venues, networks, multilateral arrangements, institutions and partnership structures.
Using theory from the policy sciences in public health research provides a basis to critically appraise the internal logic of each country’s policy but also to compare similarities and differences between the countries’ policies. This raises questions about how the national policy context influenced each country’s preferences for action on global health.
Learning Areas:Public health or related public policy
List the main components of policy design. Identify elements of policy design in policy documents related to health
Keyword(s): Public Policy, International Health
Qualified on the content I am responsible for because: I am a 4th year PhD student. The presentation submitted on policy design is a part of my thesis research on national policy development on global health, for which I am current engaged in field work in both countries. My research interests are public policy, global health and global health governance. Previously I worked for over a decade for a global professional association in health promotion developing international projects.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.